Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Integra LifeSciences
IART
$1.33B
| $41.7M | 0.03% |
609,534
-24,638
| -4% | -$1.74M |
|
|
MZTI
227
The Marzetti Company
MZTI
$3.02B
| $41.7M | 0.03% |
246,953
-15,652
| -6% | -$2.89M |
|
228
iShares Core US Aggregate Bond ETF
AGG
$137B
| $41.6M | 0.03% |
362,005
+22,564
| +7% | +$2.62M |
|
229
Webster Financial
WBS
$12.8B
| $41.4M | 0.03% |
761,058
-14,712
| -2% | -$732K |
|
230
Halozyme
HALO
$10.2B
| $40.9M | 0.03% |
1,005,438
+81,724
| +9% | +$3.42M |
|
231
CONMED
CNMD
$1.49B
| $40.9M | 0.03% |
312,547
-9,271
| -3% | -$1.21M |
|
232
ATI
ATI
$30.5B
| $40.5M | 0.03% |
2,435,145
-82,984
| -3% | -$1.57M |
|
233
Prestige Consumer Healthcare
PBH
$2.58B
| $39.3M | 0.02% |
699,687
-8,845
| -1% | -$486K |
|
234
Alcon
ALC
$33.9B
| $38M | 0.02% |
472,382
-28,853
| -6% | -$2.22M |
|
|
BHVN
235
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $37.2M | 0.02% |
+267,976
| New | +$33.5M |
|
236
Natera
NTRA
$38B
| $36.7M | 0.02% |
329,216
+125,782
| +62% | +$14.4M |
|
|
DENN
237
DELISTED
Denny's
DENN
| $35.8M | 0.02% |
2,191,557
-35,281
| -2% | -$554K |
|
238
Omnicell
OMCL
$1.64B
| $35.6M | 0.02% |
239,720
-3,762
| -2% | -$576K |
|
239
Paylocity
PCTY
$8.39B
| $35.5M | 0.02% |
126,659
+10,776
| +9% | +$2.59M |
|
240
Dine Brands
DIN
$450M
| $34.7M | 0.02% |
426,825
-9,811
| -2% | -$789K |
|
241
Kulicke & Soffa
KLIC
$4.74B
| $33.4M | 0.02% |
572,787
+139,051
| +32% | +$8.66M |
|
242
Wipro
WIT
$19.7B
| $32.7M | 0.02% |
7,412,552
-205,546
| -3% | -$899K |
|
|
BPMC
243
DELISTED
Blueprint Medicines
BPMC
| $32.5M | 0.02% |
+315,658
| New | +$29.4M |
|
244
Honeywell
HON
$76.3B
| $31.7M | 0.02% |
158,496
-4,788
| -3% | -$1.02M |
|
245
Century Aluminum
CENX
$4.55B
| $31.5M | 0.02% |
2,338,720
-61,899
| -3% | -$778K |
|
246
RLJ Lodging Trust
RLJ
$1.81B
| $31.4M | 0.02% |
2,110,830
-32,074
| -1% | -$461K |
|
247
Freshpet
FRPT
$3.28B
| $31.3M | 0.02% |
219,355
+1,774
| +0.8% | +$254K |
|
|
AAWW
248
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $31.3M | 0.02% |
382,917
-8,143
| -2% | -$586K |
|
249
Sally Beauty Holdings
SBH
$1.51B
| $31M | 0.02% |
1,840,232
-65,878
| -3% | -$1.25M |
|
250
Biogen
BIIB
$30.5B
| $30.7M | 0.02% |
108,489
+3,414
| +3% | +$1.12M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.